Dealmaking: Q3 Roundup Shows Deal Values Jump From Prior Quarter
A look at M&A and alliance activity across the medical device and in vitro diagnostics industries, July-September 2020
Executive Summary
Device company M&A values reached $17.9bn in Q3, while in vitro diagnostic firms and research tools players completed M&A activity that totaled $8.2bn.